German Cll Study Group
Clinical trials sponsored by German Cll Study Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Massive new registry to track thousands of blood cancer patients for years Results expected Dec 2026 (estimated)
- Can a Four-Drug cocktail erase traces of Hard-to-Treat leukemia? Results expected Feb 2027 (estimated)
- Can three targeted drugs tame an aggressive blood cancer? Results expected Aug 2027 (estimated)
- Major CLL trial tests which drug combo works best for new patients Results expected Sep 2027 (estimated)
-
Can three targeted drugs tame an aggressive blood cancer?
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of three targeted drugs—zanubrutinib, tislelizumab, and sonrotoclax—can effectively treat Richter transformation, a rare and aggressive form of blood cancer that can arise in people with chronic lymphocytic leukemia (CLL). The s…
Phase 2 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a triple drug combo outsmart High-Risk CLL?
Disease control Recruiting nowThis phase 3 trial is investigating whether adding acalabrutinib to a standard combination of obinutuzumab and venetoclax can help people with high-risk chronic lymphocytic leukemia (CLL) live longer without their disease progressing. The study enrolls adults with CLL who have ce…
Phase 3 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
CLL study tracks Long-Term survival after First-Line treatment
Knowledge-focused Recruiting nowThis observational study follows 2,000 people with chronic lymphocytic leukemia (CLL) who have completed first-line treatment in earlier clinical trials. Researchers will collect data from routine care to see how different treatment sequences affect overall survival, quality of l…
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Massive new registry to track thousands of blood cancer patients for years
Knowledge-focused Recruiting nowThis study is a registry that will follow up to 8,000 people with chronic lymphocytic leukemia (CLL) and related blood cancers over many years. It does not test a new treatment but instead collects information on how patients are doing over time, including survival. The goal is t…
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC